Skip to main content
Caplight Logo









Adanate

Adanate

Private
La Jolla, CaliforniaHealthcare & Life Scienceshttps://adanate.com

Last Round

Series A

Nov 17, 2021

Total Funding Raised

$30M

Company Overview

Adanate is a biotechnology company that develops antibody therapeutics aimed at boosting innate and adaptive immunity to effectively manage cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

antibody therapeuticsdrug discoveryoncologyimmunologybiotechimmune checkpointmonoclonal antibodyleukocyte immunoglobulin-like receptorsLILRBtumor microenvironmentbiologicspreclinical developmenttherapeutic pipelinedrug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Adanate Comparables

Compare Adanate with similar companies based on industry and business-model similarity.

Adanate comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Immune-Onc Therapeutics
89%
OncoResponse
82%
Biond Biologics
79%

Adanate Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ANov 17, 2021

Adanate Investors

Notable investors and investment history

Adanate investors
InvestorRounds
Westlake Village BioPartnersSeries A
Avalon VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 17, 2021

    $30M round led by Westlake Village BioPartners.

Adanate Filings

Explore SEC and related filing metadata, where available.

Adanate filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Adanate's valuation, stock price, and market status.

Is Adanate a public or private company?

Adanate is a private company.

What is the current stock price of Adanate?

Adanate is a private company with no public stock price. No recent secondary market data is available.

How much is Adanate worth (valuation)?

Valuation information for Adanate is not publicly available.

Can I buy Adanate stock?

Adanate shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Adanate's last funding round?

Adanate's most recent funding round was Series A on November 17, 2021.

Who are the main investors in Adanate?

Key investors in Adanate include Westlake Village Biopartners.

Will Adanate IPO soon?

No public IPO plans have been announced for Adanate.

How can I track Adanate secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Adanate's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLa Jolla, California
Employee Range1
Year Founded2017
Last FundingNov 17, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?